The Complete DRHP Filing Checklist: What SEBI Actually Expects in 2025

Filing a Draft Red Herring Prospectus is one of the most document-intensive exercises a company undertakes before it reaches the public markets. It is not simply a regulatory formality. The DRHP represents a company’s first formal conversation with regulators, institutional investors, and the broader market. Every disclosure, every financial restatement, every risk factor — all of it will be examined by SEBI, scrutinized by merchant bankers, and eventually read by sophisticated investors who will make capital allocation decisions based on what they find.

In 2025, SEBI has continued to tighten its expectations around disclosure quality, consistency of financial data, and the depth of risk articulation. Companies that treat DRHP preparation as a back-office documentation task — rather than as a strategic and compliance-critical process — frequently find themselves responding to multiple rounds of observations, which delay timelines and erode market confidence before a single share has been issued.

This guide is intended for CFOs, company secretaries, legal counsels, and senior management teams who are either preparing to file or are already mid-process. It outlines what SEBI actually looks for, where filings most commonly fall short, and how preparation quality directly affects how smoothly a company transitions from private to public.

Understanding the Regulatory Purpose Behind DRHP

The DRHP is not a marketing document. Companies and their advisors sometimes approach it with the instinct to present the business in its most favorable light — which is understandable but often counterproductive. SEBI’s role is investor protection, and the regulator evaluates a DRHP primarily through the lens of whether a retail investor, reading this document, would have sufficient information to make an informed decision. That framing should guide every editorial and legal decision made during preparation.

When organizations engage with professional support for drhp sebi compliance, the benefit is not just document assembly — it is institutional knowledge about how SEBI interprets ambiguous language, what disclosure gaps typically trigger observations, and how financial data needs to be reconciled across sections to avoid internal inconsistencies.

SEBI issues a set of observations after reviewing the DRHP, and these observations can range from requests for additional disclosure to more substantive concerns about financial restatements or promoter background. Companies that understand what SEBI is actually looking for — rather than just what the checklist technically requires — tend to receive fewer and less consequential observations.

The Distinction Between Compliance and Clarity

Meeting the technical checklist of required sections is not the same as satisfying SEBI’s expectation of disclosure clarity. A risk factor section, for example, may technically exist in a filing but be written so generically that it fails to communicate any company-specific exposure. SEBI has become increasingly direct about expecting risk factors that are genuinely tailored to the issuer’s business model, sector, and financial position — not boilerplate language borrowed from previous filings in the same industry.

Clarity matters because the regulator is not simply verifying that sections exist. It is assessing whether the document, read as a whole, gives investors a coherent and honest picture of the company. Contradictions between the Management Discussion and Analysis section and the financial statements, or between the business description and the risk factors, are common triggers for SEBI observations and must be identified and resolved before filing.

Financial Disclosures and Restatement Standards

SEBI requires that a DRHP contain audited financial statements for a specified number of preceding fiscal years, restated in accordance with the applicable accounting standards and SEBI’s Issue of Capital and Disclosure Requirements (ICDR) Regulations. Restatement is one of the areas where preparation tends to be most technically demanding and where errors are most difficult to correct after submission.

Restatement is not simply re-presenting previously published accounts. It involves adjusting historical financial data to reflect changes in accounting policies, prior period corrections, and any other material adjustments that are necessary to ensure comparability across the periods presented. If the company has changed its revenue recognition approach, shifted from one accounting standard to another, or has subsidiaries that were consolidated differently in prior years, all of these need to be reflected in the restated accounts with appropriate explanatory notes.

Reconciliation Across Document Sections

One of the most time-consuming aspects of DRHP preparation is ensuring that financial figures are consistent across every section that references them. The financial summary, MD&A, capital structure, and use of proceeds sections all draw on the same underlying data — but they are often drafted by different teams at different stages of the process. The result is that different sections may reference slightly different figures, use different base years, or describe financial trends in ways that are technically accurate in isolation but contradictory when read together.

SEBI’s review process is thorough enough that these discrepancies are almost always identified. Resolving them post-submission adds time and creates the impression of an organization that has not adequately reviewed its own filing. The internal reconciliation process — where every financial reference across all sections is cross-checked against the audited and restated accounts — should be completed before the document is submitted to the lead manager for their review.

Promoter Disclosure and Related Party Transactions

The disclosures around promoters, promoter group entities, and related party transactions are among the most scrutinized portions of any DRHP. SEBI’s concern here is straightforward: investors need to understand who controls the company, what financial relationships exist between the company and its promoters, and whether any of those relationships create risks or conflicts that could affect future shareholder value.

Promoter background disclosures must be complete, including prior directorships, any regulatory proceedings, and details of entities in which promoters hold significant interests. Companies sometimes underestimate how far back SEBI expects these disclosures to reach, or they omit entities that are technically controlled by family members but are not directly held by the named promoters. Either omission can result in an observation that requires the filing to be revised and resubmitted.

Materiality Thresholds in Related Party Disclosures

Related party transactions must be disclosed in accordance with the relevant accounting standard, which in India is Accounting Standard 18 as notified by the Ministry of Corporate Affairs, or Ind AS 24 for companies that have adopted Indian Accounting Standards. The DRHP must not only list these transactions but explain their commercial rationale and confirm that they were conducted on arms-length terms. Where they were not conducted on arms-length terms, full disclosure of the nature and extent of the deviation is expected.

Companies with complex group structures or with a history of intragroup transactions should expect this section to require significant time and legal review. The materiality thresholds that determine what must be disclosed are not always intuitive, and the consequences of under-disclosure are more serious than the consequences of disclosing transactions that arguably fall below any threshold.

Risk Factors: Specificity Over Coverage

The risk factors section is frequently the weakest part of a DRHP in terms of actual utility to investors. The instinct to include a broad range of generic risks — market risk, regulatory risk, competitive risk — results in a section that is long but not informative. SEBI’s observation letters have increasingly directed companies to replace or supplement generic risk factors with disclosures that are specific to the company’s actual circumstances.

A useful test for each risk factor is whether it could appear, word for word, in a competitor’s DRHP. If it could, it is probably too generic. Risk factors should reference the company’s specific markets, specific dependencies, specific regulatory exposure, and the specific ways in which an adverse development could affect its financial position. This requires the legal team drafting the section to have a genuine understanding of the business — not just the regulatory template.

Ordering and Weighting of Risk Factors

SEBI does not prescribe a specific order for risk factors, but the convention — and the expectation — is that the most material risks appear first. A company that places a relatively minor operational risk ahead of a significant litigation or regulatory exposure creates the impression of disclosure management rather than genuine transparency. The ordering of risk factors should reflect an honest internal assessment of materiality, reviewed and agreed upon by senior management, legal counsel, and the lead manager.

Use of IPO Proceeds and Objects of the Issue

Every rupee of IPO proceeds must be accounted for in the objects of the issue section. SEBI expects this section to be specific, quantified, and supported by internal documentation — capital expenditure estimates, independent appraisals where relevant, and a timeline for deployment. General corporate purposes can be included, but SEBI has imposed limits on what percentage of total proceeds can be allocated to this catch-all category, precisely because it lacks accountability.

Companies that are raising funds for acquisitions face additional disclosure requirements. Where the acquisition target has been identified, detailed disclosure about the target is expected. Where it has not been identified, the allocation is subject to scrutiny and may be capped. The objects section is one of the areas where investor interests and management flexibility are most directly in tension, and SEBI’s position consistently favors investor clarity over management optionality.

Timing, Coordination, and the Pre-Filing Review Process

One factor that distinguishes well-prepared DRHP filings from problematic ones is the internal timeline and coordination structure. DRHP preparation involves the company’s finance team, legal counsel, statutory auditors, the book running lead manager, and often specialist advisors for particular sections. Each of these parties works on different sections, and the final document needs to be integrated and reviewed as a whole before submission.

The internal review process should include at minimum one full read-through of the complete document by a senior team member who can identify inconsistencies, ambiguities, and gaps across sections. This review is distinct from the legal review and the financial review — it is an editorial review focused on coherence and completeness. Many of the observations that SEBI issues reflect errors that would have been caught by a careful, integrated read of the full document before filing.

Closing Thoughts on DRHP Readiness

SEBI’s expectations around DRHP quality have grown more demanding over successive years, and there is no indication that this trajectory will reverse. The regulator has made clear, through its observation letters and its public guidance, that it expects filings to reflect a genuine commitment to disclosure — not a technical compliance exercise.

For companies planning a public offering in 2025, the practical implication is that preparation needs to begin well before the anticipated filing date, that internal ownership of the process needs to be clearly assigned, and that the final document needs to be reviewed not just for regulatory completeness but for the kind of coherence and specificity that supports informed investor decision-making.

Companies that approach drhp sebi compliance as a process of genuine transparency — rather than a threshold to cross — tend to move through the regulatory review stage more efficiently, encounter fewer post-observation delays, and reach the market with documents that institutional investors can engage with seriously. That outcome is worth the additional preparation time it requires.